TRODELVY subst sèche 180 mg flac
7680681790013
CH-68179
L01FX17
07.16.1.
Reimbursement limitations:
TRODELVY.01
cancer du sein triple négatif (TNBC)
(avec modèle de prix)
En monothérapie dans le traitement …
1 / 3
google
Details
- Product number
- 6817901
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: sacituzumabum govitecanum 180 mg, acidum morpholinoethansulfonicum, trehalosum dihydricum, polysorbatum 80, pro vitro.
Articles (1)
TRODELVY 180 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
180.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1021.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2022
Authorization holder
Gilead Sciences Switzerland Sàrl
6300 Zug
Authorization information
- Swissmedic authorization number
- 68179
- Drug name
- TRODELVY, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L01FX17
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 09/09/2021
- Authorization expiration date
- 08/09/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TRODELVY subst sèche 180 mg flac
- Description (DE)
- TRODELVY Trockensub 180 mg Durchstf
- Market launch
- 09/09/2021
- Narcotic (BTM)
- No